Chronic nicotine causes functional upregulation of ionotropic glutamate receptors mediating hippocampal noradrenaline and striatal dopamine release

被引:38
作者
Risso, F
Parodi, M
Grilli, M
Molfino, F
Raiteri, M
Marchi, M
机构
[1] Univ Genoa, Dipartimento Med Sperimentale, Sez Farmacol & Tossicol, I-16148 Genoa, Italy
[2] Univ Genoa, Ctr Eccelenza Ric Biomed, I-16148 Genoa, Italy
关键词
chronic nicotine; glutamate receptors; NMDA receptors; AMPA receptors; noradrenaline release; dopamine release;
D O I
10.1016/S0197-0186(03)00173-6
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
It has been proposed that (-)-nicotine can activate release-stimulating presynaptic nicotinic acetylcholine receptors (nAChRs) on glutamatergic nerve terminals to release glutamate, which in turn stimulates the release of noradrenaline (NA) and dopamine (DA) via presynaptic ionotropic glutamate receptors on catecholaminergic terminals. The objective of this study was to compare the function of N-methyl-D-aspartate (NMDA) and alpha-amino-3-hydroxy-5-methylisoxazide-4-propionic acid (AMPA) glutamate receptors in synaptosomes of rat hippocampus and striatum following acute and chronic (-)-nicotine administration. In hippocampal synaptosomes, prelabeled with [H-3]NA, both the NMDA- and AMPA-evoked releases were higher in (-)-nicotine-treated (10 days) than in (-)nicotine-treated (1 day) or vehicle-treated (1 or 10 days) rats. In striatal synaptosomes prelabeled with [H-3]DA, the NMDA-evoked, but not the AMPA-evoked, release of [H-3]DA was higher in (-)-nicotine-treated (10 days) than in nicotine-treated (1 day) or vehicle-treated (1 or 10 days) animals. Chronic (-)-nicotine did not affect catecholamine uptake, basal release and release evoked by high-K+ depolarization. Thus, chronic exposure to nicotine enhances the function of ionotropic glutamate receptors mediating noradrenaline release in the hippocampus and dopamine release in the striatum. (C) 2003 Elsevier Ltd. All rights reserved.
引用
收藏
页码:293 / 301
页数:9
相关论文
共 51 条
[1]   Assessment of nicotinic acetylcholine receptor-mediated release of [3H]-norepinephrine from rat brain slices using a new 96-well format assay [J].
Anderson, DJ ;
Puttfarcken, PS ;
Jacobs, I ;
Faltynek, C .
NEUROPHARMACOLOGY, 2000, 39 (13) :2663-2672
[2]  
Arvanov VL, 1997, J PHARMACOL EXP THER, V283, P226
[3]  
BENOWITZ NL, 1990, CIBA F SYMP, V152, P186
[4]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[5]   Nicotine addiction: the possible role of functional upregulation [J].
Buisson, B ;
Bertrand, D .
TRENDS IN PHARMACOLOGICAL SCIENCES, 2002, 23 (03) :130-136
[6]   INTERACTIONS BETWEEN GLUTAMATERGIC AND MONOAMINERGIC SYSTEMS WITHIN THE BASAL GANGLIA - IMPLICATIONS FOR SCHIZOPHRENIA AND PARKINSONS-DISEASE [J].
CARLSSON, M ;
CARLSSON, A .
TRENDS IN NEUROSCIENCES, 1990, 13 (07) :272-276
[7]  
Cheramy A, 1996, J PHARMACOL EXP THER, V276, P616
[8]   Release of [H-3]-noradrenaline from rat hippocampal synaptosomes by nicotine: Mediation by different nicotinicreceptor subtypes from striatal [H-3]-dopamine release [J].
Clarke, PBS ;
Reuben, M .
BRITISH JOURNAL OF PHARMACOLOGY, 1996, 117 (04) :595-606
[9]   Neuronal nicotinic receptors, important new players in brain function [J].
Clementi, F ;
Fornasari, D ;
Gotti, C .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2000, 393 (1-3) :3-10
[10]   NICOTINE REDUCES THE BINDING OF [H-3] MK-801 TO BRAIN MEMBRANES, BUT NOT VIA THE STIMULATION OF HIGH-AFFINITY NICOTINIC RECEPTORS [J].
COURT, JA ;
PIGGOTT, MA ;
PERRY, EK .
BRAIN RESEARCH, 1990, 524 (02) :319-321